A&O Shearman
We are only able to display limited information for this firm. We display more complete information for all of the following firms:
A&O Shearman fields a highly experienced healthcare and life sciences team with a strong record across both contentious and non-contentious mandates. Drawing on deep industry insight, the practice advises clients in the biotech, medtech and pharmaceutical sectors on high-stakes patent work, commercial collaborations, regulatory challenges and growth-stage transactions. Leadership of the practice is shared by Frits Gerritzen, whose IP litigation expertise spans complex disputes involving pharma products, antibodies and medical technologies, and Christiaan de Brauw, a corporate specialist who frequently represents biotech companies and venture capital funds in M&A and investment mandates. The ‘very effective’ Jort de Groodt plays a central role in the team’s life sciences and technology offering.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- ‘Jort de Groodt has been very effective with his team to deliver the results we wanted.'
- ‘Knowledge of our company. Strategic thinking around how to approach a funding round or other event.'
Key clients
- Logex
- Protix
Work highlights
Advised Logex International Healthcare Analytics B.V - Thoma Bravo on its acquisition of LOGEX.